Donepezil hydrochloride in the treatment of senile Alzheimer's disease, early stage
Loading...
Date
2014-05-15
Authors
Berezhna, A.
Reznichenko, E.
Pavlova, O.
Journal Title
Journal ISSN
Volume Title
Publisher
Kharkiv National Medical University
Abstract
We observed five patients aged 75 to 82 years, two women and three men. Memory loss, impaired concentration, mild depression was observed in all patients. Based on clinical and paraclinical methods was diagnosed Senile Alzheimer's disease early stage. In the combined therapy was appointed donepezil hydrochloride ("Alzepil") at a dose of 5 mg at bedtime for 3 months.
Description
Keywords
alzheimer’s disease, dementia, donepezil hydrochloride
Citation
Berezhna A. V. Donepezil hydrochloride in the treatment of senile Alzheimer's disease, early stage / A. V. Berezhna, E. K. Reznichenko, O. S. Pavlova // 7th International Scientific Interdisciplinary Conference (ISIC) for medical students and young scientists, Kharkiv, May 15–16, 2014 : abstract book / KhNMU. – Kharkiv, 2014. – P. 226.